홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → 1-Methyl-5(3-methyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine HCl

HRID 1681897
인쇄

반응식

HRID 1681897 반응식
[I-].C[NH+:3]1[CH2:8][CH:7]([C:9]2[O:13][N:12]=[C:11]([CH3:14])[N:10]=2)[CH2:6][N:5]([C:15](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[CH2:4]1.[ClH:34]>C(O)(C(F)(F)F)=O>[ClH:34].[CH3:15][N:5]1[CH2:6][CH:7]([C:9]2[O:13][N:12]=[C:11]([CH3:14])[N:10]=2)[CH2:8][N:3]=[CH:4]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 313Hydrochloric AcidHCID 703426091-Methyl-3-triphenylmethyl-5(3-methyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidinium Iodide

생성물 1

HCID 703429651-Methyl-5(3-methyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine HCl

시약·촉매·용매 1

HCID 6422Trifluoroacetic acid용매2회

실험 절차

1-Methyl-3-triphenylmethyl-5(3-methyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidinium Iodide (330 mg, 0.6 mmol) was dissolved in TFA (1 mL) with stirring in a stoppered round bottom flask at room temperature. After 18 hours stirring the excess TFA was evaporated in vacuo, and the dark residue triturated with ether. The ether was decanted leaving an oily residue that was taken up in ice cold sat. Na2CO3 and then extracted with chloroform. After drying and evaporation the chloroform fraction gave the free base which was converted to its HCl salt and recrystallized (methanol/ether) to yellow crystals 15 mg (12%) identified by 300 MHz nmr and ms m/z=180.

후처리

  1. customwas evaporated in vacuo
  2. customthe dark residue triturated with ether
  3. customThe ether was decanted
  4. customleaving an oily residue that
  5. extractionextracted with chloroform
  6. customAfter drying
  7. customevaporation the chloroform fraction
  8. customgave the free base which
  9. customrecrystallized (methanol/ether) to yellow crystals 15 mg (12%)

출처 및 근거

ORD 기록
ord-509f81d715074daab28930af01856d81
출처 데이터셋
uspto-grants-1992_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05175166

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트